6 research outputs found
Transdermal Administration of Aqueous Pregabalin Solution as a Potential Treatment Option for Patients with Neuropathic Pain to Avoid Central Nervous System-Mediated Side Effects
Deprotonation Equilibrium of 5‑Tropolonediazonium Salt Strongly Favors 1,2,5-Tropoquinone-5-diazide Structure in Certain Solvents
5-Tropolonediazonium
salt <b>1</b> is a well-known intermediate
for the preparation of 5-substituted tropolone derivatives, but 1,2,5-tropoquinone-5-diazide <b>2</b>, which is expected to be formed by deprotonation of <b>1</b>, has not been reported. We synthesized <b>2</b>, and
the structures of <b>1</b> and <b>2</b> were investigated
and compared. NMR and UV spectral data indicated that <b>1</b> is easily deprotonated in water, methanol, DMSO, and DMF and exists
in the form of <b>2</b> in these solvents (but not in acetone
or acetonitrile) because of its strong acidity (estimated p<i>K</i><sub>a</sub> −2.07). Thus, the acid–base
equilibrium shows strong solvent-dependence. Compound <b>2</b> may be synthetically available as a carbene precursor
Silicon-Containing GABA Derivatives, Silagaba Compounds, as Orally Effective Agents for Treating Neuropathic Pain without Central-Nervous-System-Related Side Effects
Neuropathic
pain is a chronic condition resulting from neuronal
damage. Pregabalin, the (<i>S</i>)-isomer of 3-isobutyl-γ-aminobutyric
acid (GABA), is widely used to treat neuropathic pain, despite the
occurrence of central nervous system (CNS)-related side effects such
as dizziness and somnolence. Here we describe the pharmacology of
novel GABA derivatives containing silicon–carbon bonds, silagaba
compounds. Silagaba131, 132, and 161 showed pregabalin-like analgesic
activities in animal models of neuropathic pain, but in contrast to
pregabalin they did not impair neuromuscular coordination in rotarod
tests. Pharmacokinetic studies showed that brain exposure to silagaba
compounds was lower than that to pregabalin. Surprisingly, despite
their potent analgesic action in vivo, silagaba compounds showed only
weak binding to α2-δ protein. These compounds may be useful
to study mechanisms of neuropathic pain. Our results also indicate
that silagaba132 and 161 are candidates for orally effective treatment
of neuropathic pain without CNS-related side effects